Downloaded from Journals.Physiology.Org/Journal/Ajpgi at Univ of California Davis (169.237.106.105) on July 21, 2020

Total Page:16

File Type:pdf, Size:1020Kb

Downloaded from Journals.Physiology.Org/Journal/Ajpgi at Univ of California Davis (169.237.106.105) on July 21, 2020 UC Davis UC Davis Previously Published Works Title Xenometabolite signatures in the UC Davis type 2 diabetes mellitus rat model revealed using a metabolomics platform enriched with microbe-derived metabolites. Permalink https://escholarship.org/uc/item/9k12s743 Journal American journal of physiology. Gastrointestinal and liver physiology, 319(2) ISSN 0193-1857 Authors Mercer, Kelly E Yeruva, Laxmi Pack, Lindsay et al. Publication Date 2020-08-01 DOI 10.1152/ajpgi.00105.2020 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Am J Physiol Gastrointest Liver Physiol 319: G157–G169, 2020. First published June 8, 2020; doi:10.1152/ajpgi.00105.2020. RESEARCH ARTICLE Microbiome and Host Interactions Xenometabolite signatures in the UC Davis type 2 diabetes mellitus rat model revealed using a metabolomics platform enriched with microbe-derived metabolites Kelly E. Mercer,1,2 Laxmi Yeruva,1,2,3 Lindsay Pack,1 James L. Graham,4,5 Kimber L. Stanhope,4,5 Sree V. Chintapalli,1,2 Umesh D. Wankhade,1,2 Kartik Shankar,6 Peter J. Havel,4,5 Sean H. Adams,1,2 and X Brian D. Piccolo1,2 1Arkansas Children’s Nutrition Center, Little Rock, Arkansas; 2Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas; 3Arkansas Children’s Research Institute, Little Rock, Arkansas; 4Department of Nutrition, University of California of California, Davis, California; 5Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, California; and 6Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado Submitted 6 April 2020; accepted in final form 4 June 2020 Mercer KE, Yeruva L, Pack L, Graham JL, Stanhope KL, metabolomics platform for xenometabolites (nonself-originating me- Chintapalli SV, Wankhade UD, Shankar K, Havel PJ, Adams SH, tabolites). This assay has 190 in-house standards with the majority Piccolo BD. Xenometabolite signatures in the UC Davis type 2 enriched for microbe-derived metabolites. As a proof-of-principle, we diabetes mellitus rat model revealed using a metabolomics platform used the XenoScan to discriminate genetic differences from cecal enriched with microbe-derived metabolites. Am J Physiol Gastrointest samples associated with different rat lineages, in addition to charac- Liver Physiol 319: G157–G169, 2020. First published June 8, 2020; terizing diabetes progression in rat model of type 2 diabetes. Com- doi:10.1152/ajpgi.00105.2020.—The gut microbiome has the poten- plementing microbial sequencing data with xenometabolites uncov- tial to create or modify xenometabolites (i.e., nonhost-derived metab- ered novel microbial metabolism in targeted organisms. olites) through de novo synthesis or modification of exogenous and diabetes; metabolomics; microbiota; xenometabolites endogenous compounds. While there are isolated examples of xeno- metabolites influencing host health and disease, wide-scale character- ization of these metabolites remains limited. We developed a metabo- lomics platform (“XenoScan”) using liquid chromatography-mass INTRODUCTION spectrometry to characterize a range of known and suspected xeno- metabolites and their derivatives. This assay currently applies authen- A great deal of research has focused on the role of the gut tic standards for 190 molecules, enriched for metabolites of microbial microbiome in modulating host physiology and health, includ- origin. As a proof-of-principle, we characterized the cecal content ing associations between specific intestinal microbe popula- xenometabolomics profile in adult male lean Sprague-Dawley (LSD) tions and metabolites with the function of gastrointestinal tract and University of California, Davis type 2 diabetes mellitus (UCD- and systemic immune systems (37, 55), liver function and T2DM) rats at different stages of diabetes. These results were corre- steatosis (10), amino acid metabolism (27), gut hormone re- lated to specific bacterial species generated via shotgun metagenomic lease (11), brain development and behavior (13a), kidney sequencing. UCD-T2DM rats had a unique xenometabolite profile function (28), and other physiological systems. Some of the compared with LSD rats, regardless of diabetes status, suggesting that at least some of the variation is associated with host genetics. strongest evidence that specific bacteria or groups of bacteria Furthermore, modeling approaches revealed that several xenometabo- impact physiological function stems from fecal/cecal content lites discriminated UCD-T2DM rats at early stages of diabetes versus transfer studies, in which donor obesity phenotypes were those at 3 mo postdiabetes onset. Several xenometabolite hubs corre- transferred to recipients (47, 52). Recently, clinical application lated with specific bacterial species in both LSD and UCD-T2DM of this strategy has shown promise, with fecal transfer from rats. For example, indole-3-propionic acid negatively correlated with healthy donors to patients suffering from inflammatory bowel species within the Oscillibacter genus in UCD-T2DM rats considered disease (IBD) helping mitigate IBD-associated symptoms (54). to be prediabetic or recently diagnosed diabetic, in contrast to glu- Most studies of gut microbiome-host interactions have fo- conic acid and trimethylamine, which were positively correlated with cused on correlations between abundances of specific microbes Oscillibacter species. The application of a xenometabolite-enriched and specific (patho)physiological variables, which allows for metabolomics assay in relevant milieus will enable rapid identification hypothesis-generation in terms of the potential bacterial taxa of a wide variety of gut-derived metabolites, their derivatives, and their potential biochemical origins of xenometabolites in relationship that are involved. However, the specific molecular signals to host gastrointestinal microbial ecology. underlying microbe-to-host communication and gut-derived metabolites that reflect shifts in microbial populations, ecol- NEW & NOTEWORTHY We debut a liquid chromatography-mass ogy, and biochemistry remain to be fully elaborated. There is spectrometry (LC/MS) platform called the XenoScan, which is a a massive genetic potential (number of genes and gene vari- ants) for the gut microbiome; when coupled to the large Correspondence: S. H. Adams ([email protected]); B. D. Piccolo biomass of microbes in the gastrointestinal tract, and the ([email protected]). complex molecule mixtures in foods, there is tremendous http://www.ajpgi.org 0193-1857/20 Copyright © 2020 the American Physiological Society G157 Downloaded from journals.physiology.org/journal/ajpgi at Univ of California Davis (169.237.106.105) on July 21, 2020. G158 XENOSCAN: A LC/MS PLATFORM ENRICHED IN XENOMETABOLITES enzymatic and nonenzymatic capacity for generating xenome- mals used in this study has previously been conducted and a major tabolites. This can occur via de novo synthesis, through mi- effect of collection year was observed even though UCD-T2DM rats crobial conversion of exogenous components (e.g., phytonutri- had been maintained at the same animal facility for Ͼ12 yr (45). Thus the current study only reports results from rats collected during 2016. ents, fibers, oligosaccharides, pharmacological agents, etc.), ϭ ϭ and via microbial modification of host-derived molecules (pri- Final sample numbers (n) were as follows: LSD 7, PD 9, RD ϭ 10, and D3M ϭ 5. Since only two animals were available from mary bile acids, urea, etc.). The latter may also be referred to 6-mo diabetic rats (D6M) from 2016, these animals were not included as “cometabolites” since they involve metabolism by both host for analyses herein. and microbe(s). Much work remains to fully categorize xeno- metabolites and their nomenclature, to determine which of Sample Collection these metabolites serve as modulators of mammalian physiol- ogy, and to understand their specific microbial and food- As previously described (45), rats were given a 200 mg/kg ip dose derived origins. of pentobarbital sodium after a 13-h fast. Fully anesthetized rats were exsanguinated via cardiac puncture between ca. 0800 and 1100. Cecal Metabolomics has proven quite valuable to identify molec- tissue was immediately removed after exsanguination and blotted dry. ular biomarkers of microbial metabolism; however, few labo- A hole was punched into the cecal tissue, and a cecal content sample ratories have dedicated authentic standard libraries that encom- was squeezed into a sterile 1.5-mL microcentrifuge tube. Samples pass the wide breadth of metabolites associated with microbial were immediately placed in a Ϫ80°C freezer until analysis. activities. Furthermore, most large-scale metabolomics plat- forms have standard and spectral libraries that generally en- Metagenomic Sequencing compass human and mammalian metabolic pathways, which Total DNA was extracted from cecal content samples (0.1–0.3 g) complicates identification of microbial specific metabolites. To using the DNeasy PowerSoil HTP 96 Kit (Qiagen, Germantown, MD) address this issue, we have developed a metabolomics platform following the manufacturer’s instructions. Sequencing libraries were that enables a greater focus on “nonhost” xenometabolites, generated from extracted DNA samples using Nextera XT reagents xenometabolite derivatives, cometabolites, and related mole- including dual indexes. Libraries were quantitated using Qubit ds- cules, which can be applied to better understand alterations in DNA reagents and pooled
Recommended publications
  • Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress
    cancers Review Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress Alexandra M. Mowday 1,2, Christopher P. Guise 1,2, David F. Ackerley 2,3, Nigel P. Minton 4, Philippe Lambin 5, Ludwig J. Dubois 5, Jan Theys 5, Jeff B. Smaill 1,2 and Adam V. Patterson 1,2,* 1 Translational Therapeutics Team, Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland 1023, New Zealand; [email protected] (A.M.M.); [email protected] (C.P.G.); [email protected] (J.B.S.) 2 Maurice Wilkins Centre for Molecular Biodiscovery, School of Biological Sciences, University of Auckland, Auckland 1023, New Zealand 3 School of Biological Sciences, Victoria University of Wellington, Wellington 6140, New Zealand; [email protected] 4 The Clostridia Research Group, BBSRC/EPSRC Synthetic Biology Research Centre (SBRC) School of Life Sciences, University of Nottingham, Nottingham NG72RD, UK; [email protected] 5 Maastro (Maastricht Radiation Oncology), GROW School for Oncology and Development Biology, Maastricht University Medical Centre, 6200 MD Maastricht, The Netherlands; [email protected] (P.L.); [email protected] (L.J.D.); [email protected] (J.T.) * Correspondence: [email protected]; Tel.: +64-9-923-6941 Academic Editor: Gabi Dachs Received: 16 May 2016; Accepted: 22 June 2016; Published: 28 June 2016 Abstract: Most solid cancers contain regions of necrotic tissue. The extent of necrosis is associated with poor survival, most likely because it reflects aggressive tumour outgrowth and inflammation. Intravenously injected spores of anaerobic bacteria from the genus Clostridium infiltrate and selectively germinate in these necrotic regions, providing cancer-specific colonisation.
    [Show full text]
  • Xiexin Tang Improves the Symptom of Type 2 Diabetic Rats by Modulation of the Gut Microbiota
    www.nature.com/scientificreports OPEN Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota Received: 30 August 2017 Xiaoyan Wei, Jinhua Tao , Suwei Xiao, Shu Jiang, Erxin Shang, Zhenhua Zhu, Dawei Qian Accepted: 13 February 2018 & Jinao Duan Published: xx xx xxxx Type 2 diabetes mellitus (T2DM), a chronic metabolic disease which severely impairs peoples’ quality of life, currently attracted worldwide concerns. There are growing evidences that gut microbiota can exert a great impact on the development of T2DM. Xiexin Tang (XXT), a traditional Chinese medicine prescription, has been clinically used to treat diabetes for thousands of years. However, few researches are investigated on the modulation of gut microbiota community by XXT which will be very helpful to unravel how it works. In this study, bacterial communities were analyzed based on high-throughput 16S rRNA gene sequencing. Results indicated that XXT could notably shape the gut microbiota. T2DM rats treated with XXT exhibited obvious changes in the composition of the gut microbiota, especially for some short chain fatty acids producing and anti-infammatory bacteria such as Adlercreutzia, Alloprevotella, Barnesiella, [Eubacterium] Ventriosum group, Blautia, Lachnospiraceae UCG-001, Papillibacter and Prevotellaceae NK3B31 group. Additionally, XXT could also signifcantly ameliorate hyperglycemia, lipid metabolism dysfunction and infammation in T2DM rats. Moreover, the correlation analysis illustrated that the key microbiota had a close relationship with the T2DM related indexes. The results probably provided useful information for further investigation on its active mechanism and clinical application. T2DM, a chronic metabolic disease characterized by hyperglycemia as a result of insufcient insulin secretion, insulin action or both1, is estimated that its numbers in the adults will increase by 55% by 20352.
    [Show full text]
  • WO 2018/064165 A2 (.Pdf)
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Longitudinal Characterization of the Gut Bacterial and Fungal Communities in Yaks
    Journal of Fungi Article Longitudinal Characterization of the Gut Bacterial and Fungal Communities in Yaks Yaping Wang 1,2,3, Yuhang Fu 3, Yuanyuan He 3, Muhammad Fakhar-e-Alam Kulyar 3 , Mudassar Iqbal 3,4, Kun Li 1,2,* and Jiaguo Liu 1,2,* 1 Institute of Traditional Chinese Veterinary Medicine, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China; [email protected] 2 MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China 3 College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China; [email protected] (Y.F.); [email protected] (Y.H.); [email protected] (M.F.-e.-A.K.); [email protected] (M.I.) 4 Faculty of Veterinary and Animal Sciences, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan * Correspondence: [email protected] (K.L.); [email protected] (J.L.) Abstract: Development phases are important in maturing immune systems, intestinal functions, and metabolism for the construction, structure, and diversity of microbiome in the intestine during the entire life. Characterizing the gut microbiota colonization and succession based on age-dependent effects might be crucial if a microbiota-based therapeutic or disease prevention strategy is adopted. The purpose of this study was to reveal the dynamic distribution of intestinal bacterial and fungal communities across all development stages in yaks. Dynamic changes (a substantial difference) in the structure and composition ratio of the microbial community were observed in yaks that Citation: Wang, Y.; Fu, Y.; He, Y.; matched the natural aging process from juvenile to natural aging.
    [Show full text]
  • Clostridium Sporogenes
    (R)-Indolelactyl-CoA dehydratase, the key enzyme of tryptophan reduction to indolepropionate in Clostridium sporogenes Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften (Dr. rer. Nat.) dem Fachbereich Biologie der Philipps-Universität Marburg vorgelegt von Diplom-Chemikerin Huan Li aus JiLin VR. China Marburg/Lahn, 2014 Die Untersuchungen zur vorliegenden Arbeit wurden von September 2010 bis Dezember 2013 im Max-Planck-Institut für terrestrische Mikrobiologie, Marburg und im Laboratorium für Mikrobiologie, Fachbereich Biologie, der Philipps-Universität Marburg (Hochschulkennziffer: 1180) unter der Leitung von Prof. Dr. Wolfgang Buckel durchgeführt. Vom Fachbereich Biologie der Philipps-Universität Marburg als Dissertation am angenommen. Erstgutachter: Prof. Dr. Wolfgang Buckel Zweitgutachter: Prof. Dr. Johann Heider Tag der mündlichen Prüfung am: Für den gläubigen Menschen steht Gott am Anfang, für den Wissenschaftler am Ende aller seiner Überlegungen. Max Planck 献给最亲爱的爸爸妈妈 Index Zusammenfassung 1 Summary 2 Introduction 3 1. The role of gastrointestinal microbiota metabolites ........................................................... 3 2. Fermentation of amino acids and Stickland-reaction ......................................................... 5 3. Clostridium sporogenes ........................................................................................................... 7 4. 2-Hydroxyacyl-CoA dehydratases and the unusual radical H2O-elimination ................. 9 5. Family Ш CoA-transferases ...............................................................................................
    [Show full text]
  • Alterations in the Gut Bacterial Microbiome in Fungal Keratitis Patients
    RESEARCH ARTICLE Alterations in the gut bacterial microbiome in fungal Keratitis patients Sama Kalyana Chakravarthy1☯, Rajagopalaboopathi Jayasudha1☯, Konduri Ranjith1, Anirban Dutta2, Nishal Kumar Pinna2, Sharmila S. Mande2, Savitri Sharma1, Prashant Garg3, Somasheila I. Murthy3, Sisinthy Shivaji1* 1 Jhaveri Microbiology Centre, Brien Holden Eye Research Centre, L. V. Prasad Eye Institute, Kallam Anji Reddy campus, Hyderabad, India, 2 Bio-Sciences R&D Division, TCS Research, Tata Consultancy Services Ltd., Pune, India, 3 Tej Kohli Cornea Institute, L. V. Prasad Eye Institute, Kallam Anji Reddy campus, Hyderabad, India a1111111111 a1111111111 ☯ These authors contributed equally to this work. a1111111111 * [email protected] a1111111111 a1111111111 Abstract Dysbiosis in the gut microbiome has been implicated in several diseases including auto- immune diseases, inflammatory diseases, cancers and mental disorders. Keratitis is an OPEN ACCESS inflammatory disease of the eye significantly contributing to corneal blindness in the devel- Citation: Kalyana Chakravarthy S, Jayasudha R, oping world. It would be worthwhile to investigate the possibility of dysbiosis in the gut micro- Ranjith K, Dutta A, Pinna NK, Mande SS, et al. (2018) Alterations in the gut bacterial microbiome biome being associated with Keratitis. Here, we have analyzed fungal and bacterial in fungal Keratitis patients. PLoS ONE 13(6): populations in stool samples through high-throughput sequencing of the ITS2 region for e0199640. https://doi.org/10.1371/journal. fungi and V3-V4 region of 16S rRNA gene for bacteria in healthy controls (HC, n = 31) and pone.0199640 patients with fungal keratitis (FK, n = 32). Candida albicans (2 OTUs), Aspergillus (1 OTU) Editor: Suresh Yenugu, University of Hyderabad, and 3 other denovo-OTUs were enriched in FK samples and an unclassified denovo-OTU INDIA was enriched in HC samples.
    [Show full text]
  • Modulation of Gut Microbiota by Glucosamine and Chondroitin in a Randomized, Double-Blind Pilot Trial in Humans
    microorganisms Article Modulation of Gut Microbiota by Glucosamine and Chondroitin in a Randomized, Double-Blind Pilot Trial in Humans Sandi L. Navarro 1,* , Lisa Levy 1, Keith R. Curtis 1, Johanna W. Lampe 1,2 and Meredith A.J. Hullar 1 1 Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; [email protected] (L.L.); [email protected] (K.R.C.); [email protected] (J.W.L.); [email protected] (M.A.J.H.) 2 Department of Epidemiology, University of Washington, Seattle, WA 98195, USA * Correspondence: [email protected]; Tel.: +1-206-667-6583 Received: 31 October 2019; Accepted: 22 November 2019; Published: 23 November 2019 Abstract: Glucosamine and chondroitin (G&C), typically taken for joint pain, are among the most frequently used specialty supplements by US adults. More recently, G&C have been associated with lower incidence of colorectal cancer in human observational studies and reduced severity of experimentally-induced ulcerative colitis in rodents. However, little is known about their effects on colon-related physiology. G&C are poorly absorbed and therefore metabolized by gut microbiota. G&C have been associated with changes in microbial structure, which may alter host response. We conducted a randomized, double-blind, placebo-controlled crossover trial in ten healthy adults to evaluate the effects of a common dose of G&C compared to placebo for 14 days on gut microbial community structure, measured by 16S rRNA gene sequencing. Linear mixed models were used to evaluate the effect of G&C compared to placebo on fecal microbial alpha and beta diversity, seven phyla, and 137 genera.
    [Show full text]
  • Phosphate, Microbiota and CKD
    nutrients Review Phosphate, Microbiota and CKD Chiara Favero 1, Sol Carriazo 1,2, Leticia Cuarental 1,2, Raul Fernandez-Prado 1,2, Elena Gomá-Garcés 1, Maria Vanessa Perez-Gomez 1,2, Alberto Ortiz 1,2,*,† , Beatriz Fernandez-Fernandez 1,2,*,† and Maria Dolores Sanchez-Niño 1,2,3,*,† 1 Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Av Reyes Católicos 2, 28040 Madrid, Spain; [email protected] (C.F.); [email protected] (S.C.); [email protected] (L.C.); [email protected] (R.F.-P.); [email protected] (E.G.-G.); [email protected] (M.V.P.-G.) 2 Red de Investigacion Renal (REDINREN), Av Reyes Católicos 2, 28040 Madrid, Spain 3 School of Medicine, Department of Pharmacology and Therapeutics, Universidad Autonoma de Madrid, 28049 Madrid, Spain * Correspondence: [email protected] (A.O.); [email protected] (B.F.-F.); [email protected] (M.D.S.-N.) † These authors contributed equally to this work. Abstract: Phosphate is a key uremic toxin associated with adverse outcomes. As chronic kidney dis- ease (CKD) progresses, the kidney capacity to excrete excess dietary phosphate decreases, triggering compensatory endocrine responses that drive CKD-mineral and bone disorder (CKD-MBD). Eventu- ally, hyperphosphatemia develops, and low phosphate diet and phosphate binders are prescribed. Recent data have identified a potential role of the gut microbiota in mineral bone disorders. Thus, parathyroid hormone (PTH) only caused bone loss in mice whose microbiota was enriched in the Th17 cell-inducing taxa segmented filamentous bacteria. Furthermore, the microbiota was required Citation: Favero, C.; Carriazo, S.; for PTH to stimulate bone formation and increase bone mass, and this was dependent on bacterial Cuarental, L.; Fernandez-Prado, R.; Gomá-Garcés, E.; Perez-Gomez, M.V.; production of the short-chain fatty acid butyrate.
    [Show full text]
  • Microbial Tryptophan Catabolites in Health and Disease
    Downloaded from orbit.dtu.dk on: Sep 27, 2021 Microbial tryptophan catabolites in health and disease Roager, Henrik Munch; Licht, Tine Rask Published in: Nature Communications Link to article, DOI: 10.1038/s41467-018-05470-4 Publication date: 2018 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Roager, H. M., & Licht, T. R. (2018). Microbial tryptophan catabolites in health and disease. Nature Communications, 9(1). https://doi.org/10.1038/s41467-018-05470-4 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. REVIEW ARTICLE DOI: 10.1038/s41467-018-05470-4 OPEN Microbial tryptophan catabolites in health and disease Henrik M. Roager1,2 & Tine R. Licht 2 Accumulating evidence implicates metabolites produced by gut microbes as crucial media- tors of diet-induced host-microbial cross-talk. Here, we review emerging data suggesting that microbial tryptophan catabolites resulting from proteolysis are influencing host health.
    [Show full text]
  • Effect of Fructans, Prebiotics and Fibres on the Human Gut Microbiome Assessed by 16S Rrna-Based Approaches: a Review
    Wageningen Academic Beneficial Microbes, 2020; 11(2): 101-129 Publishers Effect of fructans, prebiotics and fibres on the human gut microbiome assessed by 16S rRNA-based approaches: a review K.S. Swanson1, W.M. de Vos2,3, E.C. Martens4, J.A. Gilbert5,6, R.S. Menon7, A. Soto-Vaca7, J. Hautvast8#, P.D. Meyer9, K. Borewicz2, E.E. Vaughan10* and J.L. Slavin11 1Division of Nutritional Sciences, University of Illinois at Urbana-Champaign,1207 W. Gregory Drive, Urbana, IL 61801, USA; 2Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE, Wageningen, the Netherlands; 3Human Microbiome Research Programme, Faculty of Medicine, University of Helsinki, Haartmaninkatu 3, P.O. Box 21, 00014, Helsinki, Finland; 4Department of Microbiology and Immunology, University of Michigan, 1150 West Medical Center Drive, Ann Arbor, MI 48130, USA; 5Microbiome Center, Department of Surgery, University of Chicago, Chicago, IL 60637, USA; 6Bioscience Division, Argonne National Laboratory, 9700 S Cass Ave, Lemont, IL 60439, USA; 7The Bell Institute of Health and Nutrition, General Mills Inc., 9000 Plymouth Ave N, Minneapolis, MN 55427, USA; 8Division Human Nutrition, Department Agrotechnology and Food Sciences, P.O. Box 17, 6700 AA, Wageningen University; 9Nutrition & Scientific Writing Consultant, Porfierdijk 27, 4706 MH Roosendaal, the Netherlands; 10Sensus (Royal Cosun), Oostelijke Havendijk 15, 4704 RA, Roosendaal, the Netherlands; 11Department of Food Science and Nutrition, University of Minnesota, 1334 Eckles Ave, St. Paul, MN 55108, USA; [email protected]; #Emeritus Professor Received: 27 May 2019 / Accepted: 15 December 2019 © 2020 Wageningen Academic Publishers OPEN ACCESS REVIEW ARTICLE Abstract The inherent and diverse capacity of dietary fibres, nondigestible oligosaccharides (NDOs) and prebiotics to modify the gut microbiota and markedly influence health status of the host has attracted rising interest.
    [Show full text]
  • Roseburia Intestinalis Is a Primary Degrader of Dietary - Mannans
    View metadata,Downloaded citation and from similar orbit.dtu.dk papers on:at core.ac.uk Mar 30, 2019 brought to you by CORE provided by Online Research Database In Technology The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary - mannans La Rosa, Sabina Leanti; Leth, Maria Louise; Michalak, Leszek; Hansen, Morten Ejby; Pudlo, Nicholas A.; Glowacki, Robert; Pereira, Gabriel; Workman, Christopher; Arntzen, Magnus; Pope, Phillip B.; Martens, Eric C.; Abou Hachem, Maher ; Westereng, Bjørge Published in: Nature Communications Link to article, DOI: 10.1038/s41467-019-08812-y Publication date: 2019 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): La Rosa, S. L., Leth, M. L., Michalak, L., Hansen, M. E., Pudlo, N. A., Glowacki, R., ... Westereng, B. (2019). The human gut Firmicute Roseburia intestinalis is a primary degrader of dietary -mannans. Nature Communications, 10(1), [905]. DOI: 10.1038/s41467-019-08812-y General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • Clostridia in Commercial Fish of the Azov and Black Seas and in Aquaculture Facilities in the Southern Region of Russia
    OnLine Journal of Biological Sciences Investigations Clostridia in Commercial Fish of the Azov and Black Seas and in Aquaculture Facilities in the Southern Region of Russia 1Yuriy Aleksandrovich Fedorov, 2Marina Aleksandrovna Morozova and 1Roman Gennad'yevich Trubnik 1Southern Federal University, 344006, 105/42 st. Bol’shaya Sadovaya, Rostov-on-Don, Russia 2Azov Fisheries Research Institute, 344002, 21 st. Beregovaya, Rostov-on-Don, Russia Article history Abstract: The paper presents studies on the infection with clostridia of fish Received: 06-11-2018 with skin lesions and ulcers on the surface of the body. The objects of study Revised: 17-01-2019 were syrman goby from the eastern part of the Taganrog Bay of the Sea of Accepted: 31-01-2019 Azov, turbot from the shelf zone of the north-eastern Black Sea and carps reared under aquaculture conditions. Using an Autoflex speed III Bruker Corresponding Author: Roman Gennad'yevich Trubnik Daltonics (Germany) mass spectrometer, by the MALDI-TOF mass Southern Federal University, spectrometry was showed that sulfite-reducing clostridia ( Clostridium 344006, 105/42 st. Bol’shaya perfringens, C. sporogenes ) have been shown to infect the organs and Sadovaya, Rostov-on-Don, tissues of syrman goby with vibriosis and turbot with ulcerative skin lesions Russia of unknown etiology. Species such as Clostridium difficile , Clostridium E-mail: [email protected] novyi are of clinical importance and were found in the parenchymal organs of carp suffering from chronic aeromonas infection on pond fish farms in the southern Russia. These bacteria are its cosmopolitan distribution ability them to generate heat-resistant spores and cause food poisoning, which makes control and prevention measures needed in the food chain.
    [Show full text]